The National Institutes of Health (NIH) is advancing precision medicine with a new cooperative agreement funding opportunity. The Model-to-Clinic (M2C) for Precision Medicine with AI (PRIMED-AI) initiative will foster the transition of AI models into clinical environments.
Scope
The overarching goal of the PRIMED-AI Program is to support the development of innovative, reliable, cost-effective, and sustainable multimodal AI-based clinical decision support (CDS) tools. By integrating clinical imaging with other multimodal health data, PRIMED-AI CDS tools will enhance care for patients with diverse health conditions and catalyze the widespread adoption of AI in clinical workflows.
Eligibility
This opportunity (RFA-RM-27-013) is open to a wide array of applicants:
- Nonprofit organizations with or without 501(c)(3) status
- Public, private, and state institutions of higher education
- State, county, city, township, and special district governments
- Native American tribal governments and organizations
- Small businesses and for-profit entities
Partnership
Due to the complex nature of integrating diverse health data streams, cross-disciplinary partnerships are highly recommended. Successful applicants will work closely with NIH through a cooperative agreement (UG3/UH3, Clinical Trial Optional) to ensure that the AI-based decision tools are robust and primed for clinical trials and eventual adoption.
Deadline: October 19, 2026
More info: https://simpler.grants.gov/opportunity/360c4588-1512-4fa4-9b61-52a3f1d6c368
Stay updated on the latest health tech funding: https://newsletter.livi.health/signup
